Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP99/02045 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO99/50262 | 10/7/1999 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3876657 | Aelony et al. | Apr 1975 | A |
4600430 | Abdulla et al. | Jul 1986 | A |
Number | Date | Country |
---|---|---|
196 890 | Feb 1985 | HU |
WO 9504045 | Feb 1995 | WO |
WO 9631485 | Oct 1996 | WO |
WO 9631486 | Oct 1996 | WO |
WO 9631487 | Oct 1996 | WO |
WO 9703967 | Feb 1997 | WO |
WO 9724122 | Oct 1997 | WO |
WO 9814432 | Apr 1998 | WO |
Entry |
---|
Burger, A. (Ed.), “Bioisosterism in molecular modification,” Medicinal Chemistry, 3rd Ed., Wiley-Interscience Division of John Wiley & Sons, 1970, Part 1, 72-80. |
King, F.D. (Ed.), “Bioisosteres, conformational restriction and pro-drugs—case history: an example of a conformational restriction approach,” Medical Chemistry: Principles and Practice, 1994, Chapter 14, 206-209. |
Thomber, C.W., “Isosterism and molecular modification in drug design,” Chem. Soc. Rev., 1979, 8, 563-580. |